{
  "id": "mhgap#risk_safety_8ad1ecd3",
  "content": "opioid withdrawal and not using illicit opioids. Maintain – Potential for abuse.\nuntil ready to cease opioid agonist treatment. – Abrupt cessation can cause withdrawal symptoms.\nMorphine 10-20 mg as an initial dose with 10 mg extra dose Sedation and respiratory depression which can Do not use in people who are sedated. Beware of\nsulphate if needed. be life threatening. Prolonged use can lead to combining with other sedatives. The person should not\ndependence. drive. Supervise dosing to minimise the risk of diversion.\nGive longer acting opioids, such as methadone or bupre-\nnorphine, once per day to outpatients, when available.\nCLASS / INDICATION MEDICATION DOSING SIDE EFFECTS CONTRAINDICATIONS / CAUTIONS\nALPHA ADRENERGIC Clonidine Start 0.1 mg 2-3 times daily. Increase as tolerated Sedation, light-headedness, dizziness, headache, Use caution in cardiac, cerebrovascular, and liver\nAGONISTS in divided doses to manage withdrawal symptoms, nausea/vomiting, dry mouth, constipation, sexual disease. Use lower doses in kidney disease.\nto a maximum of 1 mg daily. dysfunction, depression, agitation, low blood Be aware of the potential for abuse. Monitor vital\npressure, tachycardia, sinus bradycardia, and signs closely.\nTo treat opioid withdrawal\nAV block.\nDO NOT stop abruptly, as withdrawal can cause",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety opioid withdrawal and not using illicit opioids. Maintain – Potential for abuse.\nuntil ready to cease opioid agonist treatment. – Abrupt cessation can cause withdrawal symptoms.\nMorphine 10-20 mg as an initial dose with 10 mg extra dose Sedation and respiratory depression which can Do not use in people who are sedated. Beware of\nsulphate if needed. be life threatening. Prolonged use can lead to combining with other sedatives. The person should not\ndependence. drive. Supervise dosing to minimise the risk of diversion.\nGive longer acting opioids, such as methadone or bupre-\nnorphine, once per day to outpatients, when available.\nCLASS / INDICATION MEDICATION DOSING SIDE EFFECTS CONTRAINDICATIONS / CAUTIONS\nALPHA ADRENERGIC Clonidine Start 0.1 mg 2-3 times daily. Increase as tolerated Sedation, light-headedness, dizziness, headache, Use caution in cardiac, cerebrovascular, and liver\nAGONISTS in divided doses to manage withdrawal symptoms, nausea/vomiting, dry mouth, constipation, sexual disease. Use lower doses in kidney disease.\nto a maximum of 1 mg daily. dysfunction, depression, agitation, low blood Be aware of the potential for abuse. Monitor vital\npressure, tachycardia, sinus bradycardia, and signs closely.\nTo treat opioid withdrawal\nAV block.\nDO NOT stop abruptly, as withdrawal can cause Opioid withdrawal and not using illicit opioids. maintain – potential for abuse."
}